Načítá se...
Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lymphoma
PURPOSE: To evaluate the effect of rituximab monoclonal antibody (mAb) on magnetic resonance imaging (MRI) tumor volumetrics and efficacy in a rat model of central nervous system (CNS) lymphoma when delivery to the brain was optimized with osmotic blood-brain barrier disruption (BBBD). EXPERIMENTAL...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3337144/ https://ncbi.nlm.nih.gov/pubmed/21385922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2923 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|